Evidence map›Paper›PMID 33719225›Full record

ArticleJournal of Zhejiang University. Science. B2021

Expression of

Liujia Shi, Fangfang Yang, Yanyan Xu, Shoufeng Wang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Liujia ShiInstitute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Fangfang YangInstitute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Yanyan XuInstitute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Shoufeng WangInstitute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou 310058, China. sfwang@zju.edu.cn.
Zhejiang University · CNZhejiang Lab · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetylcholinesterase (AChE) is a key enzyme used to detect organophosphorus pesticide residues by the enzyme inhibition method. An accidental discovery of a mutant strain with AChE activity was made in our laboratory during the process of AChE expression by

Indexed as

AcetylcholinesteraseAnimalsBiosensing TechniquesComputational BiologyDrosophila melanogasterOrganophosphorus CompoundsPesticidesPichiaRNA SplicingAcetylcholinesteraseOrganophosphorus CompoundsPesticidesAcetylcholinesterase (AChE)Enzyme activity determinationPesticide sensitivityPichia pastoris

Identifiers

PMID33719225
PMCPMC7982331
OpenAlexW3135934553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.